Molecular Partners Financial Overview
Molecular Partners's market cap is currently $159.77M. The company's EPS TTM is $-0.687; its P/E ratio is -2.05; Molecular Partners is scheduled to report earnings on August 25, 2025, and the estimated EPS forecast is $-0.39. See an overview of income statement, balance sheet, and cash flow financials.
